About VIB (101)
Bio imaging core (1)
Business opportunities (14)
Cardiovascular medicine (21)
Cell biology (11)
Developmental biology (4)
Inflammation and immunity (38)
International PhD Program (1)
Plant biology (86)
Research Areas (2)
Structural biology (19)
Systems biology (7)
Page Content Zone 1
Zebrafish help to unravel Alzheimer’s disease
19 August 2014
A new by VIB/KU Leuven scientists gives new knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.
Over-activity of enzyme HDAC6 exacerbates symptoms of Amyotrophic Lateral Sclerosis
26 June 2014
Scientists at VIB and KU Leuven have demonstrated in fruit-flies that over-activity of the enzyme HDAC6 in the nerve ends exacerbates the symptoms of the neurodegenerative condition ALS.
Lack of energy at the basis of Parkinson’s Disease - the molecular mechanism unraveled
25 June 2014
Vanessa Morais and Bart De Strooper (VIB/KU Leuven) demonstrated how a defect in the PINK1 gene causes Parkinson’s disease.
Mechanism explains complex brain wiring
11 June 2014
Researcher Dietmar Schmucker from VIB-KU Leuven unravels a part of the mystery on 'How neurons are created and integrate with each other is one of biology’s greatest riddles.'
NERF Neurotechnology Symposium
23 April 2014
Neuro-Electronics Research Flanders invites you to its annual Neurotechnology Symposium, that will take place on May 5 and 6 in Leuven, Belgium.
New discoveries place lack of energy at the basis of Parkinson’s Disease
20 March 2014
Neuroscientists Vanessa Moraïs and Bart De Strooper from VIB and KU Leuven have demonstrated how a defect in the gene Pink1 results in Parkinson’s disease.
Our brain has switch board to guide behavior in response to external stimuli
14 February 2014
NERF-scientists demonstrate that the habenula, a specific part in our brain consisting of neural circuits, acts as a gate for sensory information, thus regulating behavior in response to external stimuli.
New technology for the detection of genetic abnormalities which lead to serious epilepsy
22 January 2014
An international consortium including researchers from VIB, the University of Antwerp and KU Leuven demonstrates that defects in the CHD2 gene lead to Dravet Syndrome, a serious form of epilepsy.
Finding the genetic causes of spinal muscular atrophy
23 September 2013
Kristien Peeters and Albena Jordanova (VIB-UA), have identified BICD2 mutations as a cause of spinal muscular atrophy (SMA). Their findings have important implications for future diagnostic tests.
Brain dysfunctions: shared mechanisms in fragile X syndrome, autism and schizophrenia at neuronal synapses
18 September 2013
Several psychiatric conditions share the same brain cell abnormalities. Claudia Bagni and her group have unraveled how a single protein orchestrates two biological processes to form proper contacts between brain cells.
Fragile X syndrome protein linked to breast cancer progression
18 September 2013
Claudia Bagni (VIB/KU Leuven, Belgium, and the University of Rome Tor Vergata, Italy), has identified the way Fragile X Mental Retardation Protein or FMRP contributes to the progression of breast cancer.
The brain is the last great frontier - Joris de Wit
15 June 2013
“When I was fourteen, I already knew I wanted to be a scientist. I was fascinated with biology and how things work. The brain is the last great frontier,” says Joris de Wit.
Exploring the process of physiological brain aging
15 June 2013
Aging is a risk factor for several neurodegenerative diseases. Little is known about the process of physiological brain aging in the absence of neurodegeneration.
25-31 August, 2013 - RNA and the Etiology of Brain Disease - Cortona, Italy
5 June 2013
The IBRO-Kemali College on “RNA and the Etiology of Brain Disease” will be held at the Neuroscience School of Advanced Studies from August 25th until August 31st, 2013.
Janssen, J&J Innovation, VIB, KU Leuven and UZ Leuven join forces to combat neurological diseases
29 May 2013
Janssen and Johnson & Johnson Innovation are launching Stellar. This project will overcome the inefficiencies in translating basic molecular insights to diagnostics and therapeutics for neurodegenerative diseases.
Page Content Zone 2
Page Content Zone 3
Get news updates:
Follow us on Twitter
Like us on Facebook
Inflammation and immunity
Training and facilities
Int. Ph.D. Program